Coventry University Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
University of Southampton Featured PhD Programmes
University of Oxford Featured PhD Programmes
University of East Anglia Featured PhD Programmes

Cancer / Oncology (radiotherapy) PhD Projects, Programs & Scholarships

We have 31 Cancer / Oncology (radiotherapy) PhD Projects, Programs & Scholarships

  • "radiotherapy" ×
  • Cancer / Oncology×
  • clear all
Order by 
Showing 11 to 20 of 31
  Releasing the cell cycle arrest with PROTACs to enhance DNA-damaging therapies

Funding Type

PhD Type

PhD Studentships of the North West Cancer Research (NWCR) Centre. The NWCR Centre comprises a network research groups from across the NW of England who work on basic and translational aspects of cancer biology.
  Inflammation in the tumour microenvironment
  Dr E Parkes, Dr J Rehwinkel
Application Deadline: 10 January 2020

Funding Type

PhD Type

THE PROJECT. A key part of tackling cancer is understanding the tumour microenvironment, in particular the immune microenvironment.
  An intelligent scheme to identify novel drug targets through analysing the DNA repairome in drug resistant cancer?
  Research Group: Biomedical Research Group
  Prof C Parris
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  Investigating the anti-cancer effect of hop β -acid Lupulone and its synthetic derivatives on breast cancer cells
  Research Group: Biomedical Research Group
  Dr G Pirianov
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  The impact of mixed radiation and chemicals exposure on neuronal cytotoxicity, ageing and transcription
  Dr R Anderson
Application Deadline: 6 January 2020

Funding Type

PhD Type

A 3-year funded PhD studentship is available in the College of Health and Life Sciences at Brunel University London. Project description.
  Discovery of novel cancer immunotherapeutic agents
  Dr Y Mehellou
Applications accepted all year round

Funding Type

PhD Type

Although cancer therapeutics, mainly chemotherapy and radiotherapy, have been extremely useful in the treatment of cancer, this disease is still associated with high morbidity and mortality.
  Cancer and comorbidity: impact of comorbid conditions on equity of access and safety and outcomes of cancer treatments
  Prof J van der Meulen, Prof A Hutchings, Prof D Cromwell, Prof E Nolte
Application Deadline: 5 January 2020

Funding Type

PhD Type

The configuration of cancer services is rapidly changing. Service delivery is being re-designed in order to diagnose cancer earlier, accelerate access to treatment, improve patients’ experience, reduce side-effects of treatment and enhance cures for cancer.
  MRC DiMeN Doctoral Training Partnership: Harnessing Autophagy for the Clinical benefit of Oropharyngeal Squamous Cell Carcinoma
  Prof P Lovat, Dr M Robinson
Application Deadline: 6 January 2020

Funding Type

PhD Type

Oropharyngeal squamous cell carcinoma (OPSCC) accounts for 97,000 deaths annually worldwide with an increasing incidence attributed to human papillomavirus (HPV).
  Reversing multidrug chemoresistance in head and neck cancer
  Dr M T Teh
Applications accepted all year round

Funding Type

PhD Type

Background. Multidrug resistance renders chemotherapeutic treatment failure in large proportion of head and neck squamous cell carcinoma (HNSCC) patients requiring multimodal therapy involving chemotherapy in conjunction with surgery and/or radiotherapy.
  Use of highly multi-modal PET and MRI data as a predictive biomarker of the site of recurrence in neuro-oncology
  Dr R Hinz, Dr David Coope, Prof A Jackson
Applications accepted all year round

Funding Type

PhD Type

Primary brain tumour including glioblastoma (GBM), the most aggressive and most common form in adults, continue to have a socioeconomic impact that is disproportionate to the tumour frequency due to our inability to obtain a cure in the vast majority of adult sufferers.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.